Latest News and Press Releases
Want to stay updated on the latest news?
-
New findings challenge the longstanding assumption that postmortem tissue accurately represents the living brain and creates new frontier for drug research
-
BPGbio has completed phase 2b enrollment in late August this year for treatment of GBM with BPM31510Data further validate the MOA of BPM31510’s direct targeting of mitochondrial redox machinery to...
-
BOSTON, Oct. 14, 2025 (GLOBE NEWSWIRE) -- BPGbio, Inc., a biology-first, AI-powered, clinical-stage biopharma company focused on mitochondrial medicine and protein homeostasis, today welcomes Sheikh...
-
Company strengthens its late-stage trials with enhanced clinical and commercial leadership for its BPM31510 programs
-
BOSTON, Sept. 24, 2025 (GLOBE NEWSWIRE) -- BPGbio, Inc., a biology-first, AI-powered, clinical-stage biopharma focused on mitochondrial biology and protein homeostasis, today announced its...
-
Seasoned AI-Biotech veteran strengthens the company’s leadership in AI and mitochondrial medicine Co-Inventor of AI platform boosts company’s momentum in advancing late-stage assets to...
-
BPGbio Announces Completion of Enrollment for Phase 2b Trial of BPM31510 for Glioblastoma (GBM) and Topline Phase 2b clinical data expected in 1H 2026
-
BPM31510 provides encouraging evidence of the potential for transformative benefit for a disease with high unmet need, supporting further development.The Company plans to seek guidance in Q3 2025 from...
-
BPGbio Presents Advances in Spatial Omics Technology and Targeted Protein Degradation Insights at ASMS 2025
-
BPGbio CEO Dr. Niven R. Narain was named to The Medicine Maker Power List 2025.